Viewing Study NCT03257761


Ignite Creation Date: 2025-12-24 @ 12:50 PM
Ignite Modification Date: 2026-05-09 @ 3:03 PM
Study NCT ID: NCT03257761
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2017-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
Sponsor: University of Southern California
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extrahepatic Bile Duct Adenocarcinoma, Biliary Type View
None Gallbladder Adenocarcinoma, Biliary Type View
None Metastatic Pancreatic Adenocarcinoma View
None Recurrent Cholangiocarcinoma View
None Recurrent Gallbladder Carcinoma View
None Recurrent Hepatocellular Carcinoma View
None Recurrent Intrahepatic Cholangiocarcinoma View
None Recurrent Pancreatic Carcinoma View
None Stage III Gallbladder Cancer AJCC V7 View
None Stage III Hepatocellular Carcinoma AJCC v7 View
None Stage III Intrahepatic Cholangiocarcinoma AJCC v7 View
None Stage III Pancreatic Cancer AJCC v6 and v7 View
None Stage IIIA Gallbladder Cancer AJCC v7 View
None Stage IIIA Hepatocellular Carcinoma AJCC v7 View
None Stage IIIB Gallbladder Cancer AJCC v7 View
None Stage IIIB Hepatocellular Carcinoma AJCC v7 View
None Stage IIIC Hepatocellular Carcinoma AJCC v7 View
None Stage IV Gallbladder Cancer AJCC v7 View
None Stage IV Hepatocellular Carcinoma AJCC v7 View
None Stage IV Pancreatic Cancer AJCC v6 and v7 View
None Stage IVA Gallbladder Cancer AJCC v7 View
None Stage IVA Hepatocellular Carcinoma AJCC v7 View
None Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 View
None Stage IVB Gallbladder Cancer AJCC v7 View
None Stage IVB Hepatocellular Carcinoma AJCC v7 View
None Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 View
None Unresectable Gallbladder Carcinoma View
None Unresectable Pancreatic Carcinoma View
Keywords: